Dedicated to Finding New Medicines Through Targeting the Ubiquitin Pathway

News Headlines


Dr. Tauseef Butt, President and CEO, spoke with Cambridge Healthtech Institute on small molecules, specifically inhibitors of ubiquitin protease 7 (USP7), and their roel in immune oncology. Listen to the podcast here.

Learn More >


Upcoming Meetings

Progenra President, Dr. Tauseef Butt, has been invited to speak at the “Targeting The Ubiquitin Proteasome System” session at  Cambridge Healthtech Institute’s 15th Annual Discovery on Target: Cancer Immunotherapy. September 25-28, 2017.

Learn More >


Business Development

Progenra is seeking industry partnerships for licensing opportunities surrounding the company’s small molecule portfolio Drug Discovery Platform


Learn More >